Simphotek has been selected as one of the showcase companies for the 2020-2021 NCI SBIR Investor Initiatives. As a MedTech company, it will be showcased at an investor conference Digital RESI on September 14-16, 2020!
Scientia, 2019 – Simphotek treatment planning and computational dosimetry software Dosie™ can be pivotal in widespread adaptation of Photodynamic therapy in treating cancer. We have just published our outreach article in the leading science communication publicati...
International Photodynamic Association World Congress, 2019 (Boston, USA) – Simphotek announces a new addition to its simulation software Dosie™ - near real-time finite element (FE) solver that accurately simulates light intensity distribution for interstitial type PDT...
SPIE BiOS, 2019 (Optical Methods for Tumor Treatment and Detection) – We introduce our Dosie modeling software that helps in predicting outcomes of Photodynamic therapy (PDT) against cancer. It can be used as a dosimetry and treatment planning software for intracavitar...
Cancers, 2017 (Special Issue: Photodynamic Cancer Therapy) – Treatment planning and real-time dosimetry optimize and further advance the utilization of I-PDT to treat locally-advanced cancerous tumors.
(A) Laser treatment fibers, (B) Computer simulation of light propag...
TechNews, Apr 2016 (NJ Tech Council) – Simphotek collaborates with leading cancer research institutions to address a critical unmet need: fast computing system for photodynamic therapy planning and monitoring.
Researchers at Penn providing Photodynamic Therapy (PDT)
